Related Experiment Video
Updated: Mar 22, 2026

09:47
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
4.7K
Mimicking Retinal Development and Disease With Human Pluripotent Stem Cells
Investigative Ophthalmology & Visual Science
|April 27, 2016
Summary
Human pluripotent stem cells (hPSCs) offer powerful models for studying human development and disease, particularly retinal development and disorders. However, challenges in cell maturation and culture environments must be addressed for effective therapeutic applications.
Area of Science:
- Developmental Biology
- Stem Cell Research
- Ophthalmology
Background:
- Human pluripotent stem cells (hPSCs) possess remarkable differentiation capabilities, recapitulating early human development.
- This capacity enables the study of previously inaccessible developmental stages and offers potential for disease modeling and regenerative medicine.
Purpose of the Study:
- To review the utility of hPSCs in modeling retinal development.
- To discuss the application of hPSCs in modeling retinal disorders and screening therapeutics.
- To highlight challenges and future directions in using hPSCs for retinal research.
Main Methods:
- Review of existing literature on hPSC differentiation and retinal development.
- Analysis of studies employing hPSCs for modeling retinal diseases.
- Discussion of experimental limitations and therapeutic potential.
Main Results:
- hPSCs can recapitulate key aspects of retinal lineage development in vitro.
- hPSC-based models show promise for studying the pathophysiology of retinal disorders.
- Successful application of hPSCs in disease modeling and therapeutic screening is demonstrated.
Conclusions:
- hPSCs are valuable tools for understanding retinal development and disease.
- Further research is needed to overcome limitations in cell maturation and culture for clinical translation.
- hPSC technology holds significant potential for advancing ophthalmology and regenerative therapies.
Related Concept Videos
Induced Pluripotent Stem Cells
28.5K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.5K
Induced Pluripotent Stem Cells
6.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.1K
iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K

